Seeking Alpha
 

Sequenom, Inc. (SQNM)

- NASDAQ
  • Mar. 1, 2013, 9:17 AM
    An upgrade to Overweight by Piper Jaffray has Sequenom (SQNM) up 7.5% premarket to $4.42, vs. Piper's raised price target of $6.50. Of some 10 analysts covering the maker of DNA detection and sequencing equipment, seven are at Buy or Outperform vs. just one rating it at Underperform.
    | Comment!
  • Mar. 1, 2013, 9:10 AM
    Premarket gainers: ISRG +9%. SHS +8%. CERS +8%. DECK +8%. SQNM +7%. BBY +6%. PGH +5%.
    Losers: AT -34%. FWLT -17%. OVTI -15%. RNIN -14%. IEP -12%. ENMD -12%. YOKU -11%. SD -8%. LYG -8%. CWH -6%. RBS -6%. DB -5%.
    | Comment!
  • Jan. 9, 2013, 5:22 PM
    After-hours top gainers, as of 5:15 p.m.: VOXX +15%. NEWL +9%. SQNM +6%. PSMT +6%. XCO +6%.
    After-hours top losers: QUIK -9%. RT -9%. HAFC -7%. NKTR -7%. HALO -7%.
    | 1 Comment
  • Jan. 7, 2013, 4:03 PM
    Sequenom (SQNM -2.3%) goes into the close a bit stronger than it started out the day, recovering some of its earlier 6% dip on some upbeat preliminary FY12 guidance posted over the weekend. The company said that it is expecting revenues of $89M, equating to a Y/Y growth rate of 59%, but the results were largely overshadowed by Illumina's (ILMN -7.3%) acquisition of Verinata, whose competing verifi test - which analyzes fetal DNA naturally found in a pregnant women's blood to look for missing or extra copies of chromosomes - carry's less risk than Sequenom’s SEQureDx technology.
    | 2 Comments
  • Jan. 7, 2013, 9:10 AM
    Premarket gainers: PPHM +27%. CBMX +25%. EPOC +22%. NSM +18%. ES +11%. VVUS +10%. WAC +9%. KERX +6%. SCTY +6%. NCT +6%.
    Losers: ILMN -9%. SQNM -6%.
    | 2 Comments
  • Dec. 17, 2012, 3:32 PM
    Sequenom (SQNM -1%) bounces back after saying the USPTO has withdrawn the patent on the company's Diagnosing Fetal Chromosomal Aneuploidy Using Massively Parallel Genomic Sequencing. The agency said it was withdrawn in connection with an anticipated patent interference proceeding between parties with pending patent applications or issued patents directed to similar subject matter.
    | Comment!
  • Dec. 17, 2012, 9:10 AM
    Premarket gainers: JVA +12%. ENZN +10%. CBMX +10%. LXRX +9%. TROX +6%. CTIC +5%.
    Losers: NBG -13%. CLWR -11%. SQNM -6%.
    | Comment!
  • Nov. 26, 2012, 12:27 PM
    Shares of Sequenom (SQNM +7%) jump today after Stephens upgraded the stock to Overweight based on the American College of Obstetricians and Gynecologists Committee on Genetics recommendation that cell-free fetal DNA testing be used in high-risk women. The firm also doubles its price target to $8 from $4.
    | Comment!
  • Nov. 21, 2012, 2:13 PM
    Sequenom (SQNM +12.2%) shares surge today after the American College of Obstetricians and Gynecologists Committee on Genetics and the Society for Maternal-Fetal Medicine Publications Committee issue a joint opinion recommending that cell-free fetal DNA testing be offered to patients at increased risk of aneuploidy, and also as a follow-up test for women with a positive first-trimester or second-trimester screening test result.
    | Comment!
  • Nov. 21, 2012, 12:45 PM
    Midday top 10 gainers: MEMS +72%. NLP +38%. ARCI +20%. INFI +14%. VVUS +14%. NCTY +13%. SKX +12%. SQNM +11%. PSUN +11%. MTSL +11%. Midday top 10 Losers: STV -46%. ZLC -29%. CNET -18%. SCHL -18%. TLYS -17%. STJ -14%. CLNT -13%. EBR -11%. HGSH -11%. KID -11%.
    | 1 Comment
  • Nov. 21, 2012, 9:10 AM
    Premarket gainers: MEMS +86%. VELT +10%. SQNM +6%. MIPS +5%. CRUS +5%.
    Losers: STV -43%. SCHL -23%. TLYS -15%. ACRX -10%. EBR -10%.
    | Comment!
  • Nov. 12, 2012, 5:15 PM
    Sequenom (SQNM) says it's achieved positive results from a study of its RetnaGene AMD laboratory-developed test, which is designed to accurately predict the risk of disease progression of age-related macular degeneration. The announcement was made during its presentation today at the 2012 Joint Meeting of the American Academy of Ophthalmology and the Asia-Pacific Academy of Ophthalmology in Chicago. Shares +0.3% AH.
    | Comment!
  • Nov. 12, 2012, 9:10 AM
    Premarket gainers: TIE +43%. JEF +24%. MYRX +17%. CXS +15%. GILD +12%. CELG +10%. SVNT +7%. SQNM +7%. LUK +7%. RIMM +6%. NKTR +6%. STV +5%. DNDN +5%. CEL +5%. PCP +5%.
    Losers: CLVS -41%. STSI -20%. NBG -11%.
    | Comment!
  • Nov. 9, 2012, 12:45 PM
    Midday top 10 gainers: HWG +66%. KIPS +41%. KYAK +27%. ZIP +25%. SQNM +22%. UBNT +19%. DGIT +17%. SQI +16%. CYTX +16%. ISIS +15%. Midday top 10 Losers: GRPN -27%. DTSI -26%. SCLN -24%. IDN -23%. RNDY -21%. III -17%. ADEP -17%. OSG -17%. STRA -16%. PTIX -15%.
    | Comment!
  • Nov. 8, 2012, 5:17 PM
    Sequenom (SQNM): Q3 EPS loss of $0.26 misses by $0.02. Revenue $22.9M misses by $280K. (PR)
    | Comment!
  • Nov. 8, 2012, 12:10 AM
    Notable earnings after Thursday’s close: AFFY, AGO, CBOU, CUBE, DAR, DGIT, DIS, DLB, DNN, EGLE, EVEP, GRPN, HALO, HOGS, IGT, IO, JAZZ, JWN, LGF, MCHP, MDRX, MKL, NVDA, PSA, RNDY, SD, SPRD, SQNM, UBNT, WPRT, WR, ZGNX, ZIP
    | Comment!
SQNM vs. ETF Alternatives
Company Description
Sequenom Inc is a molecular diagnostic testing and genetics analysis company which provides molecular diagnostic testing services.
Sector: Healthcare
Industry: Biotechnology
Country: United States